AFLIBERCEPT-AYYH

AFLIBERCEPT-AYYH was reported 101 times

AFLIBERCEPT-AYYH is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OPTIC DISC DRUSEN 1 0.0159
1 MIDDLE CEREBRAL ARTERY STROKE 1 0.0088
2 RETINAL DRUSEN 1 0.0061
3 VITREOUS DEGENERATION 1 0.0061
4 BORDERLINE GLAUCOMA 1 0.0054
5 RETINAL OCCLUSIVE VASCULITIS 1 0.0045
6 EPIRETINAL MEMBRANE 1 0.0036
7 RETINOPATHY HYPERTENSIVE 1 0.0033
8 RETINAL VASCULAR DISORDER 1 0.0017
9 CATARACT NUCLEAR 1 0.0015
10 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 2 0.0014
11 EYELID FUNCTION DISORDER 1 0.0013
12 CHOROIDAL NEOVASCULARISATION 1 0.0012
13 DEVICE LOOSENING 1 0.0012
14 PUNCTATE KERATITIS 1 0.0011
15 METAMORPHOPSIA 2 0.0011
16 RETINAL EXUDATES 1 0.0011
17 ENDOPHTHALMITIS 6 0.0010
18 ONYCHALGIA 1 0.0010
19 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
20 CORNEAL ABRASION 1 0.0007
21 MEDICAL PROCEDURE 1 0.0006
22 RETINITIS 1 0.0006
23 VITRITIS 1 0.0005
24 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
25 OCULAR HYPERTENSION 1 0.0005
26 HYPERAEMIA 1 0.0005
27 INTERCEPTED PRODUCT ADMINISTRATION ERROR 3 0.0004
28 VITREOUS HAEMORRHAGE 1 0.0004
29 IRIDOCYCLITIS 1 0.0003
30 THROMBOSIS IN DEVICE 1 0.0003
31 INJECTION SITE INFECTION 1 0.0003
32 UVEITIS 4 0.0003
33 MACULOPATHY 1 0.0003
34 RETINOPATHY 1 0.0003
35 HORDEOLUM 1 0.0002
36 BLINDNESS UNILATERAL 3 0.0002
37 PRODUCT LABEL CONFUSION 1 0.0002
38 INTERCEPTED PRODUCT PREPARATION ERROR 2 0.0002
39 SCOLIOSIS 1 0.0002
40 HERPES SIMPLEX 1 0.0002
41 PRODUCT LABEL ISSUE 1 0.0001
42 ONYCHOCLASIS 1 0.0001
43 HAIR GROWTH ABNORMAL 1 0.0001
44 RETINAL HAEMORRHAGE 1 0.0001
45 BLINDNESS TRANSIENT 1 0.0001
46 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
47 SPINAL OSTEOARTHRITIS 1 0.0001
48 FACIAL PAIN 1 0.0001
49 RETINAL DETACHMENT 1 0.0001
50 TREATMENT FAILURE 9 0.0001
51 EYE PAIN 6 0.0001
52 EYE INFLAMMATION 1 0.0001
53 NEEDLE ISSUE 3 0.0001
54 EYELID OEDEMA 1 0.0001
55 MACULAR DEGENERATION 1 0.0001
56 EYE HAEMORRHAGE 1 0.0001
57 DIALYSIS 1 0.0001
58 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
59 LYMPHOMA 1 0.0001
60 EYE DISORDER 2 0.0001
61 DRY EYE 3 0.0001
62 DEVICE USE ERROR 2 0.0001
63 PHOTOPHOBIA 1 0.0001
64 GASTRIC ULCER 1 0.0001
65 LOWER LIMB FRACTURE 1 0.0001
66 DISABILITY 1 0.0001
67 SNEEZING 1 0.0000
68 OCULAR HYPERAEMIA 2 0.0000
69 PRESYNCOPE 1 0.0000
70 DIABETES MELLITUS 3 0.0000
71 EXPOSURE VIA SKIN CONTACT 1 0.0000
72 NERVOUSNESS 2 0.0000
73 DEAFNESS 1 0.0000
74 HAEMOPTYSIS 1 0.0000
75 INTENTIONAL DOSE OMISSION 1 0.0000
76 EYE IRRITATION 2 0.0000
77 PRODUCT SUBSTITUTION ISSUE 2 0.0000
78 LACRIMATION INCREASED 1 0.0000
79 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
80 DRUG INTOLERANCE 3 0.0000
81 GAIT INABILITY 1 0.0000
82 BLINDNESS 1 0.0000
83 POLLAKIURIA 1 0.0000
84 VISION BLURRED 3 0.0000
85 BLOOD CHOLESTEROL INCREASED 1 0.0000
86 COUGH 6 0.0000
87 PRODUCTIVE COUGH 1 0.0000
88 AGGRESSION 1 0.0000
89 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
90 INFLAMMATION 1 0.0000
91 DEPRESSED MOOD 1 0.0000
92 OXYGEN SATURATION DECREASED 1 0.0000
93 CEREBROVASCULAR ACCIDENT 3 0.0000
94 ILL-DEFINED DISORDER 1 0.0000
95 VISUAL IMPAIRMENT 2 0.0000
96 AMNESIA 1 0.0000
97 DEVICE DIFFICULT TO USE 1 0.0000
98 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
99 DRUG DOSE OMISSION BY DEVICE 1 0.0000
100 PRODUCT STORAGE ERROR 1 0.0000
101 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
102 ADVERSE EVENT 1 0.0000
103 NEUROPATHY PERIPHERAL 1 0.0000
104 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
105 ILLNESS 1 0.0000
106 ASTHMA 1 0.0000
107 RHEUMATOID ARTHRITIS 1 0.0000
108 LOSS OF CONSCIOUSNESS 1 0.0000
109 MEMORY IMPAIRMENT 1 0.0000
110 OFF LABEL USE 6 0.0000
111 HYPOAESTHESIA 1 0.0000
112 INJECTION SITE PAIN 2 0.0000
113 HEADACHE 4 0.0000
114 URINARY TRACT INFECTION 1 0.0000
115 MYOCARDIAL INFARCTION 1 0.0000
116 NO ADVERSE EVENT 1 0.0000
117 MUSCLE SPASMS 1 0.0000
118 CHEST PAIN 1 0.0000
119 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
120 ABDOMINAL PAIN UPPER 1 0.0000
121 HYPERTENSION 1 0.0000
122 DIARRHOEA 3 0.0000
123 INCORRECT DOSE ADMINISTERED 1 0.0000
124 BACK PAIN 1 0.0000
125 FEELING ABNORMAL 1 0.0000
126 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
127 FATIGUE 3 0.0000
128 WEIGHT DECREASED 1 0.0000
129 DYSPNOEA 2 0.0000
130 ANXIETY 1 0.0000
131 DEATH 3 0.0000
132 PRODUCT DOSE OMISSION ISSUE 1 0.0000
133 PNEUMONIA 1 0.0000
134 DRUG INEFFECTIVE 4 0.0000
135 ASTHENIA 1 0.0000
136 ARTHRALGIA 1 0.0000
137 DIZZINESS 1 0.0000